UTHR
United Therapeutics Corporation$542.43-2.97 (-0.54%)Prev Close$545.40·MCap$23.12B·P/E19.47·Vol264.0K·Yield—
▲
Buys (12M)
1
$863.9K
▼
Sells (12M)
119
$594.29M
◆
Net Activity
Net Seller
$593.43M
●
Active Insiders
11
last 12 mo
Over the past 12 months, insider activity at United Therapeutics Corporation (UTHR) has been dominated by selling, with 1 insider purchase totaling $863.9K and 119 insider sales totaling $594.29M. The most recent insider transaction was by ROTHBLATT MARTINE A (director, officer: Chairperson & CEO), who sold $5.22M worth of shares on Jun 12, 2026. United Therapeutics Corporation operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $23.12B.
UTHR Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $549.23 | $5.22M | 49,931 |
| Jun 12, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $549.29 | $5.49M | 28,830-26% |
| Jun 11, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $545.83 | $5.19M | 49,413 |
| Jun 10, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $549.32 | $5.22M | 49,522 |
| Jun 9, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $547.49 | $5.20M | 48,551 |
| Jun 9, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $547.50 | $5.48M | 27,311-27% |
| Jun 8, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $547.62 | $5.20M | 48,276 |
| Jun 5, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 9,880 | $546.36 | $5.40M | 28,276-26% |
| Jun 5, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $546.33 | $5.19M | 49,893 |
| Jun 4, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $547.61 | $5.20M | 49,612 |
| Jun 4, 2026 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 8,300 | $547.07 | $4.54M | 53,272 |
| Jun 2, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $547.87 | $5.48M | 27,436-27% |
| Jun 2, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 11,000 | $551.73 | $6.07M | 48,648 |
| Jun 1, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $553.83 | $5.26M | 49,733 |
| May 29, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $565.63 | $5.66M | 28,556-26% |
| May 29, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $565.64 | $5.37M | 49,718 |
| May 28, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $575.40 | $5.47M | 48,534 |
| May 27, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 9,240 | $573.19 | $5.30M | 28,851 |
| May 27, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 8,000 | $572.38 | $4.58M | 49,968 |
| May 27, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Buy | 1,500 | $575.96 | $863.9K | 43,153 |
| May 26, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $567.74 | $5.39M | 49,966 |
| May 22, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $564.11 | $5.64M | 28,836-26% |
| May 22, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $564.11 | $5.36M | 49,973 |
| May 21, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $565.98 | $5.38M | 49,573 |
| May 21, 2026 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 8,300 | $562.82 | $4.67M | 53,362 |
| May 20, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $567.94 | $5.40M | 49,962 |
| May 19, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $567.31 | $5.67M | 28,676-26% |
| May 19, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $567.04 | $5.39M | 49,880 |
| May 18, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,180 | $568.00 | $5.21M | 48,536 |
| May 15, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 9,840 | $574.55 | $5.65M | 28,113-26% |
| May 15, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $574.48 | $5.46M | 49,973 |
| May 14, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $578.65 | $5.50M | 48,635 |
| May 13, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $578.38 | $5.49M | 49,773 |
| May 13, 2026 | Mesa Nilda | director | Sell | 258 | $581.94 | $150.1K | 5,028 |
| May 12, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $573.03 | $5.73M | 27,587-27% |
| May 12, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $573.10 | $5.44M | 48,848 |
| May 11, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 8,800 | $579.23 | $5.10M | 27,756 |
| May 11, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 18,840 | $571.59 | $10.77M | 49,513-28% |
| May 7, 2026 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 8,300 | $586.75 | $4.87M | 53,392 |
| May 7, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,340 | $589.61 | $5.51M | 49,813 |
| May 6, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,260 | $576.42 | $5.34M | 49,973 |
| May 5, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,460 | $577.01 | $5.46M | 49,853 |
| May 5, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 9,920 | $577.00 | $5.72M | 28,716-26% |
| May 4, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $570.58 | $5.42M | 49,813 |
| May 1, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $572.63 | $5.44M | 49,653 |
| May 1, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $572.61 | $5.73M | 28,614-26% |
| Apr 30, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $571.22 | $5.43M | 50,005 |
| Apr 29, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $568.04 | $5.40M | 49,774 |
| Apr 28, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $568.81 | $5.40M | 48,511 |
| Apr 28, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $568.83 | $5.69M | 27,160-27% |
Showing 1–50 of 246
1 / 5
UTHR Insider Buying Activity
The following table shows recent insider purchases of United Therapeutics Corporation (UTHR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Buy | 1,500 | $575.96 | $863.9K | 43,153 |
UTHR Insider Selling Activity
The following table shows recent insider sales of United Therapeutics Corporation (UTHR) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $549.23 | $5.22M | 49,931 |
| Jun 12, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $549.29 | $5.49M | 28,830-26% |
| Jun 11, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $545.83 | $5.19M | 49,413 |
| Jun 10, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $549.32 | $5.22M | 49,522 |
| Jun 9, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $547.49 | $5.20M | 48,551 |
| Jun 9, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $547.50 | $5.48M | 27,311-27% |
| Jun 8, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $547.62 | $5.20M | 48,276 |
| Jun 5, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 9,880 | $546.36 | $5.40M | 28,276-26% |
| Jun 5, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $546.33 | $5.19M | 49,893 |
| Jun 4, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $547.61 | $5.20M | 49,612 |
| Jun 4, 2026 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 8,300 | $547.07 | $4.54M | 53,272 |
| Jun 2, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $547.87 | $5.48M | 27,436-27% |
| Jun 2, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 11,000 | $551.73 | $6.07M | 48,648 |
| Jun 1, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $553.83 | $5.26M | 49,733 |
| May 29, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $565.63 | $5.66M | 28,556-26% |
| May 29, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $565.64 | $5.37M | 49,718 |
| May 28, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $575.40 | $5.47M | 48,534 |
| May 27, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 9,240 | $573.19 | $5.30M | 28,851 |
| May 27, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 8,000 | $572.38 | $4.58M | 49,968 |
| May 26, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $567.74 | $5.39M | 49,966 |
| May 22, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $564.11 | $5.64M | 28,836-26% |
| May 22, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $564.11 | $5.36M | 49,973 |
| May 21, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $565.98 | $5.38M | 49,573 |
| May 21, 2026 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 8,300 | $562.82 | $4.67M | 53,362 |
| May 20, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $567.94 | $5.40M | 49,962 |
| May 19, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $567.31 | $5.67M | 28,676-26% |
| May 19, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $567.04 | $5.39M | 49,880 |
| May 18, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,180 | $568.00 | $5.21M | 48,536 |
| May 15, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 9,840 | $574.55 | $5.65M | 28,113-26% |
| May 15, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $574.48 | $5.46M | 49,973 |
| May 14, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $578.65 | $5.50M | 48,635 |
| May 13, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $578.38 | $5.49M | 49,773 |
| May 13, 2026 | Mesa Nilda | director | Sell | 258 | $581.94 | $150.1K | 5,028 |
| May 12, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $573.03 | $5.73M | 27,587-27% |
| May 12, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $573.10 | $5.44M | 48,848 |
| May 11, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 8,800 | $579.23 | $5.10M | 27,756 |
| May 11, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 18,840 | $571.59 | $10.77M | 49,513-28% |
| May 7, 2026 | MAHON PAUL A | officer: EVP & GENERAL COUNSEL | Sell | 8,300 | $586.75 | $4.87M | 53,392 |
| May 7, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,340 | $589.61 | $5.51M | 49,813 |
| May 6, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,260 | $576.42 | $5.34M | 49,973 |
| May 5, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,460 | $577.01 | $5.46M | 49,853 |
| May 5, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 9,920 | $577.00 | $5.72M | 28,716-26% |
| May 4, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $570.58 | $5.42M | 49,813 |
| May 1, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $572.63 | $5.44M | 49,653 |
| May 1, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $572.61 | $5.73M | 28,614-26% |
| Apr 30, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $571.22 | $5.43M | 50,005 |
| Apr 29, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $568.04 | $5.40M | 49,774 |
| Apr 28, 2026 | ROTHBLATT MARTINE A | director, officer: Chairperson & CEO | Sell | 9,500 | $568.81 | $5.40M | 48,511 |
| Apr 28, 2026 | EDGEMOND JAMES | officer: CFO AND TREASURER | Sell | 10,000 | $568.83 | $5.69M | 27,160-27% |
UTHR Insiders
ROTHBLATT MARTINE A
director, officer: Chairperson & CEO
Bought $863.9KSold $557.36M
123 tradesLast: Jun 12, 2026
Similar Stocks to UTHR
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B
NBIX
Neurocrine Biosciences, Inc.
$159.90-1.73%
$16.40B